Literature DB >> 16687502

Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8.

Vittorio Vellani1, Mariantonella Colucci, Roberta Lattanzi, Elisa Giannini, Lucia Negri, Pietro Melchiorri, Peter A McNaughton.   

Abstract

Small mammalian proteins called the prokineticins [prokineticin 1 (PK1) and PK2] and two corresponding G-protein-coupled receptors [prokineticin receptor 1 (PKR1) and PKR2] have been identified recently, but the physiological role of the PK/PKR system remains mostly unexplored. Bv8, a protein extracted from frog skin, is a convenient and potent agonist for both PKR1 and PKR2, and injection of Bv8 in vivo causes a potent and long-lasting hyperalgesia. Here, we investigate the cellular basis of hyperalgesia caused by activation of PKRs. Bv8 caused increases in [Ca]i in a population of isolated dorsal root ganglion (DRG) neurons, which we identified as nociceptors, or sensors for painful stimuli, from their responses to capsaicin, bradykinin, mustard oil, or proteases. Bv8 enhanced the inward current carried by the heat and capsaicin receptor, transient receptor potential vanilloid 1 (TRPV1) via a pathway involving activation of protein kinase Cepsilon (PKCepsilon), because Bv8 caused translocation of PKCepsilon to the neuronal membrane and because PKC antagonists reduced both the enhancement of current carried by TRPV1 and behavioral hyperalgesia in rodents. The neuronal population expressing PKRs consisted partly of small peptidergic neurons and partly of neurons expressing the N52 marker for myelinated fibers. Using single-cell reverse transcriptase-PCR, we found that mRNA for PKR1 was mainly expressed in small DRG neurons. Exposure to GDNF (glial cell line-derived neurotrophic factor) induced de novo expression of functional receptors for Bv8 in a nonpeptidergic population of neurons. These results show that prokineticin receptors are expressed in nociceptors and cause heat hyperalgesia by sensitizing TRPV1 through activation of PKCepsilon. The results suggest a role for prokineticins in physiological inflammation and hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687502      PMCID: PMC6674238          DOI: 10.1523/JNEUROSCI.3870-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  37 in total

1.  Mechanisms of Bv8-induced biphasic hyperalgesia: increased excitatory transmitter release and expression.

Authors:  Milena De Felice; Pietro Melchiorri; Michael H Ossipov; Todd W Vanderah; Frank Porreca; Lucia Negri
Journal:  Neurosci Lett       Date:  2012-05-26       Impact factor: 3.046

Review 2.  The prokineticins: a novel pair of regulatory peptides.

Authors:  Qun-Yong Zhou
Journal:  Mol Interv       Date:  2006-12

Review 3.  Receptor-targeting mechanisms of pain-causing toxins: How ow?

Authors:  Christopher J Bohlen; David Julius
Journal:  Toxicon       Date:  2012-04-14       Impact factor: 3.033

Review 4.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

5.  CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons.

Authors:  Vittorio Vellani; Chiara Sabatini; Chiara Milia; Gianfranco Caselli; Marco Lanza; Ornella Letari; Lucio Claudio Rovati; Chiara Giacomoni
Journal:  Br J Pharmacol       Date:  2019-11-07       Impact factor: 8.739

Review 6.  The prokineticin system: an interface between neural inflammation and pain.

Authors:  Silvia Franchi; Paola Sacerdote; Alberto Panerai
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

7.  Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes.

Authors:  Matthew Neal; Jie Luo; Dilshan S Harischandra; Richard Gordon; Souvarish Sarkar; Huajun Jin; Vellareddy Anantharam; Laurent Désaubry; Anumantha Kanthasamy; Arthi Kanthasamy
Journal:  Glia       Date:  2018-09-12       Impact factor: 7.452

8.  Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones.

Authors:  Vittorio Vellani; Anna M Kinsey; Massimiliano Prandini; Sabine C Hechtfischer; Peter Reeh; Pier C Magherini; Chiara Giacomoni; Peter A McNaughton
Journal:  Mol Pain       Date:  2010-09-27       Impact factor: 3.395

9.  Glial cell line-derived neurotrophic factor family ligands enhance capsaicin-stimulated release of calcitonin gene-related peptide from sensory neurons.

Authors:  B S Schmutzler; S Roy; C M Hingtgen
Journal:  Neuroscience       Date:  2009-03-11       Impact factor: 3.590

Review 10.  The molecular basis of pain and its clinical implications in rheumatology.

Authors:  Brendan Bingham; Seena K Ajit; David R Blake; Tarek A Samad
Journal:  Nat Clin Pract Rheumatol       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.